UBS Downgrades HEALTHSOUTH (HLS) to Neutral
Tweet Send to a FriendGet Alerts HLS Hot Sheet
Price: $29.72 +0.58%
Rating Summary:
8 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
8 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade HLS Now!
UBS downgraded HEALTHSOUTH (NYSE: HLS) from Buy to Neutral.
For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.
Shares of HEALTHSOUTH closed at $25.10 yesterday, with a 52 week range of $18.44-$25.39.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on HEALTHSOUTH click here. For more ratings news on HEALTHSOUTH click here.
Shares of HEALTHSOUTH closed at $25.10 yesterday, with a 52 week range of $18.44-$25.39.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Starts Insmed (INSM) at Buy
- KeyBanc Downgrades Sanderson Farms (SAFM) to Hold
- Goldman Sachs Upgrades Enbridge (ENB) to Conviction Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
